IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $393,058 | -12.3% | 40,816 | -3.1% | 0.01% | 0.0% |
Q2 2023 | $448,114 | -0.7% | 42,116 | -1.9% | 0.01% | -16.7% |
Q1 2023 | $451,476 | -17.7% | 42,916 | -3.1% | 0.01% | -14.3% |
Q4 2022 | $548,728 | +19.5% | 44,288 | +0.1% | 0.01% | 0.0% |
Q3 2022 | $459,000 | -16.1% | 44,262 | -6.6% | 0.01% | -12.5% |
Q2 2022 | $547,000 | – | 47,413 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |